Influência do teor protéico da dieta hipocalórica e do sexo sobre a perda e posterior manutenção do peso em gatos obesos

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Clinical, biomechanical and histological study on oophorectomy induced menopause

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Short periods of food restriction do not affect growth, survival or muscle development on pacu larvae

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Low-intensity resistance training attenuates dexamethasone-induced atrophy in the flexor hallucis longus muscle

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Mutagenic potential of Cordia ecalyculata alone and in association with Spirulina maxima for their evaluation as candidate anti-obesity drugs

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Caracterização de compósitos produzidos por VARTM para aplicações aeronáuticas

In recent years the aeronautic industries has increased investment in areas of technological research aiming at materials that offer better performance, safety, weight reduction and fuel consumption. For this reason the most studied materials are polymeric materials, due to their higher mechanical strength and higher stiffness. This work evaluated characteristics of two composite laminates produced from the same process, but they differed only in regions where the resin was injected and the vacuum position. The composite laminates were SC-79 resin reinforced with glass fiber fabric (plain weave) processed via VARTM. For this reason the material was subjected to mechanical tests such as: tensile, and fatigue following standards ASTM D 3039 and ASTM D 3479, respectively. The latter was observed the S-N curve. It was performed the ultrassonic C-scan analysis to check impregnation of the fiber. Considering that the process was the same for the two laminates, with small variations in the injection and in vacum ports, it was expected to find similar characteristics

Manifestações oculares na leishmaniose

The Canine Visceral Leishmaniasis is a chronic disease of endemic character, caused by Leishmania Chagasi in Americas. The inoculation of the promastigote form in the individual triggers a local and widespread immune reaction with formation of inflammatory infiltrates and deposition of immune complexes in tissues. Initial clinical symptoms of the disease are: weight reduction, hepatomegaly, splenomegaly and, according to the disease chronicity, signs such as alopecia, erythema, onychogryphosis, arthropathies, renal diseases, pyoderma, seborrheic dermatitis, muscle atrophy and Ocular diseases. Ocular diseases are often reported and are result of the direct parasitism or immune-mediated mechanisms caused by the disease. The Leishmania spp have greater affinity for the anterior segment, so that anterior uveitis is one of the most frequently diagnosed injuries. Blepharitis diffuse and Keratoconjunctivitis also appear as important ocular changes. In histological section, inflammatory infiltrates and macrophages with amastigote form are observed in all ocular tissues, with the exception of the retina and optical nerve. In the clinical analysis and disease diagnosis, should be considered the differential diagnosis, such as Ehrlichiosis and systemic hypertension, because these may cause some ocular manifestations similar to those observed in leishmaniasis

Doenças osteoarticulares em pequenos animais

Osteoarticular diseases are very frequent in small animals, especially dogs. Osteoarthritis is the most common degenerative arthropathy in cats and dogs. It is one of the most important skeletal disease in small animals and it is divided into two broad classes: secondary and genetics. The secondary is originated from situations that can cause joint instability like as trauma, ligament problems and obesity among others. The gene for osteoarthritis comes from hereditary problems such as hip dysplasia, elbow dysplasia and other diseases that can cause articular instability. The hereditary osteoarticular diseases are important only because they can result in the osteoarthritis. It is important to prevent the joint instability and consequently the clinical signs that affect the quality of life of the animals. The most common clinical signs are intermittent claudication, a decrease in performance, reluctance to jump and climb ladders among others. To prevent the clinical signs or mitigate them, the treatments need to be focused on pain control and especially restoration of the affected joint. The treatments most used are the medical and surgery. Anti-inflammatory and analgesics are used in large scale for pain control and to inhibit inflammatory mediators. Furthermore, medical treatment includes weight reduction, physiotherapy and proper nutrition along with anti-inflammatory and analgesics. Surgical treatments are indicated if there is an inadequate response to medical treatment. Physiotherapy is often used in conjunction with other treatments. Besides the reduction of weight is essential and obesity is unacceptable. Cats also suffer from osteoarthritis, but the diagnosis is rarer than in dogs. Usually the cat’s owners relate the reluctance to jump and drop in performance with senility, and when the disease is diagnosed is already in... (Complete abstract click electronic access below)

Processamento de peças em materiais compósitos para o projeto BAJA SAE

The weight of a vehicle has always been considered an extreme important factor, because it interferes in the performance, steering, consume, environmental impact, wear of components, among the others. Because of the new demand, consume reduction aim and gases emission increased the necessity to manufacture lighter vehicles, guaranteeing the complying with the gas emission international law. Besides the legal demand, the low weight will certainly be essential for the competitiveness for the next generation of vehicles. It is with this thinking the composite materials have been introduced in the automobilist industry, because those materials show an excellent relation of strength/weight, providing a reduction of consume and the increase of load capacity. Those factors justify the increase of interest of industry and the necessity of optimization of those materials and of their process. For this research, the field of application will be the Baja SAE Project, a project that is fully developed by engineering students, where they build a prototype single seat, off-road category, for use on hilly slopes with obstacle. This research aims to study two key components of the prototype are made of composite materials, analyzing all the processing. In addition, there is the analysis of the viability of this production parts to a Baja SAE vehicle, in order to increase their performance and reduce their weight without reducing the safety and robustness of the prototype. It was possible to achieve weight reduction of the steering subsystem with manufacturing the flywheel hybrid composite (carbon/glass) and the replacement of SAE 1010 steel by hybrid composite (carbon/aramid) in CVT box. The importance of this study is to obtain a good project for the vehicle of technical and scientific manner, contributing to the know-how to the team and providing a basis for optimization for upcoming projects

Risco, saúde e obesidade na prática de trabalho dos policiais militares do Estado de São Paulo

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Estudo da aderência entre o concreto celular e as barras de aço

Pós-graduação em Engenharia Civil - FEIS

Análise de agrupamentos para a classificação de pacientes submetidos à cirurgia bariátrica Fobi-Capella

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Influência da adição do nióbio no comportamento mecânico e microestrutural do aço SAE 6150

Pós-graduação em Engenharia Mecânica - FEG

Efeitos preventivos do exercício físico na expressão da miostatina em ratos tratados com Dexametasona

Muscle atrophy is always associated with Dexamethasone (Dexa) treatment, however the mechanisms are not completely understood. This study investigated the effects of Dexa on myostatin and p70S6K protein expression and if previous exercise training (T) can attenuate these effects. Eighty rats were distributed into 4 groups: sedentary control (SC), sedentary treated with Dexa (SD; 0,5 mg/kg per day, i.p., 10 days), trained control (TC) and trained treated with Dexa (TD) and underwent a training period where they were either submitted to a running protocol (60% of physical capacity, 5 days/week for 8 weeks) or kept sedentary. After T period, animals underwent Dexa treatment concomitant with training. Western Blot was performed to identify myostatin and p70S6k protein expression in the tibialis anterior (TA) and soleus (SOL) muscle. Ten days of Dexa treatment increased fasting glucose (SD=+62%), however previous T attenuated this increase (TD=+20%, p<0.05). Dexa determined significant decrease in body weight in TD (-22%) and SD (-25%), followed by TA weight reduction in SD (-23%) and TD (-20%). Previous training could not avoid these decreases. Myostatin protein expression was not altered by dexa treatment or training in TA muscle but in SOL muscle it was significantly modified after T, regardless of treatment (TC=+%23 and TD=+25) compared with their respective controls. The protein p70S6K was not modified neither by dexa nor training in any of the analyzed muscle or condition. The results of this study allowed us to conclude that previous training attenuates the hyperglycemia induced by Dexa, however it did not prevent the body or muscle weight reductions. Even in the presence of muscle atrophy, the expression of myostatin and p70S6K do not justify the mechanisms of muscle loss induced by Dexa, which suggests that other catabolic or anabolic proteins could be involved in the process of muscle atrophy after 10 days of treatment with Dexa

Pressor mechanisms in adriamycin-induced nephropathy with hypertension in rats

We explored the role of angiotensin II and vasopressin in the maintenance of blood pressure during the nephrotic syndrome of adriamycin-induced nephropathy in rats. All 91 rats treated with adriamycin developed chronic renal failure with nephrotic syndrome, which was more pronounced in the normotensive rats than the 35% who became hypertensive. Angiotensin II blockade with DuP 753 produced a significantly greater hypotensive response in both the adriamycin-hypertensive (-16 +/- 3 mm Hg) and adriamycin-normotensive (-14 +/- 5 mm Hg) groups than the saline-treated controls (-5 +/- 1 mm Hg, P < .05). Vasopressin blockade with either a V1V2 inhibitor or a selective V1 inhibitor produced a hypotensive response in adriamycin-hypertensive rats only (by -16 +/- 4 and -17 +/- 2 mm Hg, respectively, P < .01), although the nonselective vasopressin inhibitor produced similar fluid loss and body weight reduction in all three groups. The data suggest that in adriamycin-induced nephropathy with nephrotic syndrome, angiotensin II contributes to blood pressure maintenance in both hypertensive and normotensive animals, whereas the pressor action of vasopressin contributes to elevated blood pressure in hypertensive animals only.